APPROACHES TO EARLY DETECTION OF ARTERIAL HYPERTENSION
Keywords:
arterial hypertension; early diagnosis; screening; home blood pressure monitoring; ambulatory monitoring; cardiovascular risk; primary care.Abstract
Arterial hypertension is a leading modifiable contributor to cardiovascular morbidity and premature mortality. Because elevated blood pressure is frequently asymptomatic, early detection depends on systematic measurement rather than symptom-based consultation. This narrative review examines standardized office measurement, home blood pressure monitoring, ambulatory monitoring, and risk-based screening in adult populations. International recommendations from the World Health Organization, European Society of Cardiology, and United States Preventive Services Task Force were compared. The reviewed guidance supports repeated, properly performed measurements and, where feasible, out-of-office confirmation to distinguish sustained hypertension from white-coat and masked phenotypes. Screening is particularly relevant for adults with obesity, diabetes, kidney disease, cardiovascular disease, or a family history of hypertension. Integration of validated devices, staff training, clear referral pathways, and patient education may improve early recognition in primary care. No original patient observations or experimental results are claimed. Early detection should be combined with cardiovascular risk evaluation and timely follow-up to reduce preventable complications.
References
1.World Health Organization. Hypertension. Fact sheet. Updated September 25, 2025. https://www.who.int/news-room/fact-sheets/detail/hypertension
2.McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024;45(38):3912–4018. https://doi.org/10.1093/eurheartj/ehae178
3.Mancia G, et al. 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension. 2023;41(12):1874–2071. https://doi.org/10.1097/HJH.0000000000003480
4.US Preventive Services Task Force. Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2021;325(16):1650–1656. https://doi.org/10.1001/jama.2021.4987
5.NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. Lancet. 2021;398:957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
6.Stergiou GS, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. Journal of Hypertension. 2021;39(7):1293–1302. https://doi.org/10.1097/HJH.0000000000002843
7.Muntner P, et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73(5):e35–e66. https://doi.org/10.1161/HYP.0000000000000087
8.Shimbo D, et al. Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42–e63. https://doi.org/10.1161/CIR.0000000000000803




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal